NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · VIJAYA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Vijaya Diagnostic Centre Limited’s quoted price sits in the upper half of its reported 52-week range, 7.98% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Vijaya Diagnostic Centre Limited’s forward annual dividend is ₹2.00 per share, paid annual. The forward yield is 0.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Vijaya Diagnostic Centre Limited’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of ₹5.54. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vijaya Diagnostic Centre Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vijaya Diagnostic Centre Limited delivers a broad spectrum of diagnostic services to patients across India. Its extensive laboratory offerings include clinical biochemistry, haematology (and immune-haematology), clinical pathology, histopathology, cytopathology, microbiology, serology, cytogenetics, and molecular pathology. For imaging, the company provides advanced radiology services such as magnetic resonance imaging (MRI), multi-slice CT, 3D dental CBCT, mammography, DEXA/bone densitometry, ultrasound with color doppler, nuclear medicine including PET/CT, and digital X-rays. Beyond these, specialized services cover cardiology, neurology, and gastroenterology. The center also offers health check-up packages and convenient home sample collection. Headquartered in Hyderabad, India, and founded in 1981, Vijaya Diagnostic Centre operates a significant network of 80 diagnostic centers and 11 reference laboratories. These facilities are spread across 13 cities and towns, primarily in Telangana and Andhra Pradesh, alongside the National Capital Region and Kolkata.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 | May 12, 2025 | ₹3.45-7.51% vs estimate | ₹1.73B-3.98% vs estimate |
|---|
| Q3 2025 | Feb 12, 2025 | ₹3.40-2.86% vs estimate | ₹1.69B-0.6% vs estimate |
|---|
| Q2 2025 | Nov 7, 2024 | ₹4.10+7.89% vs estimate | ₹1.83B+5.61% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
₹1,907.20-₹4.50 (-0.24%)
Dr. Lal PathLabs Limited’s quoted price sits in the upper half of its reported 52-week range, 6.45% below the high.
₹546.90-₹6.95 (-1.25%)
Metropolis Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
₹455.15-₹60.35 (-11.71%)
Thyrocare Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 31.25% below the high.
₹315.50-₹4.05 (-1.27%)
Suraksha Diagnostic Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.36% below the high.
₹506.00+₹8.05 (+1.62%)
Krsnaa Diagnostics Limited’s quoted price sits in the lower half of its reported 52-week range, 39.62% below the high.
